Literature DB >> 9459212

Reading ability and processing in Duchenne muscular dystrophy and spinal muscular atrophy.

C Billard1, P Gillet, M Barthez, C Hommet, P Bertrand.   

Abstract

We analysed the reading abilities and processing of 21 children with Duchenne muscular dystrophy (DMD), 11 matched children suffering from spinal muscular atrophy (SMA) and 42 children receiving normal education. The principal result observed was that the DMD children exhibited a reading age which was significantly lower than the SMA children compared with their chronological age. These learning disabilities were not related to a deficit in non-verbal performance intelligence, but psycholinguistic evaluation showed a deficit in verbal intelligence, especially in the Similarities and Arithmetic WISC-R subtests, in phonological abilities, oral word repetition, and in digit span score. The results for the DMD children were heterogeneous, and ranged from normal to greater or lesser involvement. In an attempt to clarify the nature of this reading impairment in DMD children, the three groups (DMD, SMA, and normal control children) were tested by reading aloud a list of single words and non-words. The DMD children were significantly impaired in reading non-words, suggesting reading disability similar to dysphonetic dyslexia, the most frequent subtype of developmental dyslexia. These results are discussed in the light of psychometric data available for our DMD population and in the light of previous studies. The practical consequences of diagnosis on rehabilitation are very important. The precise description of the cognitive deficits seen in DMD is of value for future clinical and genetic studies.

Entities:  

Mesh:

Year:  1998        PMID: 9459212     DOI: 10.1111/j.1469-8749.1998.tb15351.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  25 in total

1.  Two children with muscular dystrophies ascertained due to referral for diagnosis of autism.

Authors:  Lonnie Zwaigenbaum; Mark Tarnopolsky
Journal:  J Autism Dev Disord       Date:  2003-04

2.  Verbal and memory skills in males with Duchenne muscular dystrophy.

Authors:  V J Hinton; R J Fee; E M Goldstein; D C De Vivo
Journal:  Dev Med Child Neurol       Date:  2007-02       Impact factor: 5.449

3.  Poor facial affect recognition among boys with duchenne muscular dystrophy.

Authors:  V J Hinton; R J Fee; D C De Vivo; E Goldstein
Journal:  J Autism Dev Disord       Date:  2006-12-20

Review 4.  The muscular dystrophies: from genes to therapies.

Authors:  Richard M Lovering; Neil C Porter; Robert J Bloch
Journal:  Phys Ther       Date:  2005-12

5.  Selective deficits in verbal working memory associated with a known genetic etiology: the neuropsychological profile of duchenne muscular dystrophy.

Authors:  V J Hinton; D C De Vivo; N E Nereo; E Goldstein; Y Stern
Journal:  J Int Neuropsychol Soc       Date:  2001-01       Impact factor: 2.892

6.  Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy.

Authors:  Bo Deng; David Glanzman; James G Tidball
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

7.  Investigation of Poor Academic Achievement in Children with Duchenne Muscular Dystrophy.

Authors:  V J Hinton; D C De Vivo; R Fee; E Goldstein; Y Stern
Journal:  Learn Disabil Res Pract       Date:  2004-08

Review 8.  Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.

Authors:  Caroline Perronnet; Cyrille Vaillend
Journal:  J Biomed Biotechnol       Date:  2010-06-17

9.  Delayed developmental language milestones in children with Duchenne's muscular dystrophy.

Authors:  Shana E Cyrulnik; Robert J Fee; Darryl C De Vivo; Edward Goldstein; Veronica J Hinton
Journal:  J Pediatr       Date:  2007-05       Impact factor: 4.406

10.  Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy.

Authors:  Peter J Taylor; Grant A Betts; Sarah Maroulis; Christian Gilissen; Robyn L Pedersen; David R Mowat; Heather M Johnston; Michael F Buckley
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.